Increased intestinal permeability in active pulmonary sarcoidosis.
Altered permeability of the gut is a well-described feature in Crohn's disease. Because of pathologic similarities between Crohn's disease and sarcoidosis, we initiated this study to evaluate the permeability of the gut mucosal lining in patients with pulmonary sarcoidosis. A group of 18 patients with biopsy-proven pulmonary sarcoidosis (active n = 8, inactive n = 10) were included in the study. Control groups included 22 patients with Crohn's disease (active n = 12, inactive n = 10), nine untreated patients with recent pulmonary tuberculosis, six patients with coal worker's pneumoconiosis (CWP), eight patients with idiopathic pulmonary fibrosis (IPF), and 16 healthy subjects. All were nonsmokers. The 24-h urinary excretion of 100 microCi 51Cr-ethylenediaminetetraacetic acid (51Cr-EDTA) was used to test the intestinal permeability (IP). As previously demonstrated, patients with active Crohn's disease demonstrated a dramatic increase in IP (7.7 +/- 1.4%) that was clearly reduced in inactive CD (2.34 +/- 0.54%). Patients with active pulmonary sarcoidosis exhibited a marked increased IP to 51Cr-EDTA (4 +/- 0.54%), which was not found in patients with inactive sarcoidosis (1.6 +/- 0.17%). IP was normal in patients with pulmonary tuberculosis (1.03 +/- 0.25%), CWP (2.1 +/- 0.54%), and IPF (1.9 +/- 0.33%) and did not differ from the control group (1.76 +/- 0.23%). In addition, in 6 patients with active pulmonary sarcoidosis, the concentrations of albumin and hyaluronan were measured in jejunal perfusion fluid and compared with those obtained from 10 patients with active Crohn's disease and 16 control subjects.(ABSTRACT TRUNCATED AT 250 WORDS)
Wallaert
B
B
Service de Pneumologie et Immunoallergologie, Hôpital A. Calmette, Lille, France.
Colombel
J F
JF
Adenis
A
A
Marchandise
X
X
Hallgren
R
R
Janin
A
A
Tonnel
A B
AB
D000418:Albumins / Q000032:analysis; D001706:Biopsy; D002860:Chromium Radioisotopes; D003424:Crohn Disease / Q000378:metabolism; D004492:Edetic Acid; D006801:Humans; D006820:Hyaluronic Acid / Q000032:analysis; D007408:Intestinal Absorption / Q000502:physiology*; D007413:Intestinal Mucosa / Q000378:metabolism / Q000473:pathology; D007583:Jejunum / Q000378:metabolism; D008171:Lung Diseases / Q000378:metabolism*; D011009:Pneumoconiosis / Q000378:metabolism; D011658:Pulmonary Fibrosis / Q000378:metabolism; D012507:Sarcoidosis / Q000378:metabolism*; D014397:Tuberculosis, Pulmonary / Q000378:metabolism
D000418:Albumins; D002860:Chromium Radioisotopes; D006820:Hyaluronic Acid; D004492:Edetic Acid